{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:56:37Z","timestamp":1793620597716,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008463","name":"Universitas Airlangga","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Global Epidemiology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.gloepi.2023.100113","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T15:09:44Z","timestamp":1686409784000},"page":"100113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Prevalence of medication adherence and glycemic control among patients with type 2 diabetes and influencing factors: A cross-sectional study"],"prefix":"10.1016","volume":"5","author":[{"given":"Budi","family":"Suprapti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zamrotul","family":"Izzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ade Giriayu","family":"Anjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareta Rindang","family":"Andarsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenny Putri","family":"Nilamsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cahyo Wibisono","family":"Nugroho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gloepi.2023.100113_bb0005","author":"Boyko"},{"key":"10.1016\/j.gloepi.2023.100113_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.gloepi.2023.100113_bb0015","series-title":"Essential Medicines and Health Products Information Portal","article-title":"Adherence to long-term therapies \u2013 Evidence for action","author":"World Health Organization","year":"2003"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100113_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-019-3656-1","article-title":"Using peer education to improve diabetes management and outcomes in a low-income setting: a randomized controlled trial","volume":"20","author":"Seuring","year":"2019","journal-title":"Trials."},{"issue":"3","key":"10.1016\/j.gloepi.2023.100113_bb0025","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s11096-014-9929-6","article-title":"The association between the measurement of adherence to anti-diabetes medicine and the HbA1c","volume":"36","author":"Doggrell","year":"2014","journal-title":"Int J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.gloepi.2023.100113_bb0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1464-5491.2012.03703.x","article-title":"Patient factors and glycaemic control - associations and explanatory power","volume":"29","author":"Rogvi","year":"2012","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.gloepi.2023.100113_bb0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/jdi.12175","article-title":"Factors associated with good glycemic control among patients with type 2 diabetes mellitus","volume":"5","author":"Ahmad","year":"2014","journal-title":"J Diabetes Investig"},{"issue":"4","key":"10.1016\/j.gloepi.2023.100113_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.24171\/j.phrp.2018.9.4.05","article-title":"Factors that correlate with poor glycemic control in type 2 diabetes mellitus patients with complications","volume":"9","author":"Haghighatpanah","year":"2018","journal-title":"Osong Public Health Res Perspect"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100113_bb0045","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.chest.2020.03.010","article-title":"Sample size estimation in clinical research from randomized controlled trials to observational studies","volume":"158","author":"Wang","year":"2020","journal-title":"Chest."},{"issue":"5","key":"10.1016\/j.gloepi.2023.100113_bb0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.9734\/jsrr\/2020\/v26i530263","article-title":"Sample size determination in survey research","volume":"26","author":"Adam","year":"2020","journal-title":"J Sci Res Reports"},{"issue":"5","key":"10.1016\/j.gloepi.2023.100113_bb0055","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s11096-009-9312-1","article-title":"Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes","volume":"31","author":"Van Roozendaal","year":"2009","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.gloepi.2023.100113_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0738-3991(98)00107-4","article-title":"The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence","volume":"37","author":"Svarstad","year":"1999","journal-title":"Patient Educ Couns"},{"issue":"9","key":"10.1016\/j.gloepi.2023.100113_bb0065","first-page":"340","article-title":"Treatment adherence to oral glucose-lowering agents in people with diabetes: using the brief medication questionnaire","volume":"19","author":"Istilli","year":"2015","journal-title":"J Diabetes Nurs"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100113_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/2158244016643748","article-title":"Treatment adherence and quality of life in diabetes mellitus patients in Indonesia","volume":"6","author":"Perwitasari","year":"2016","journal-title":"SAGE Open"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100113_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-020-00567-7","article-title":"Predictors of poor adherence to antidiabetic therapy in patients with type 2 diabetes: a cross-sectional study insight from Ethiopia","volume":"12","author":"Demoz","year":"2020","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100113_bb0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology."},{"issue":"8","key":"10.1016\/j.gloepi.2023.100113_bb0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100113_bb0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40200-018-0356-4","article-title":"Adherence to medications, self-care activity, and HbA1c status among patients with type 2 diabetes living in an urban area of Iran","volume":"17","author":"Jafarian-Amirkhizi","year":"2018","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.gloepi.2023.100113_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/PPA.S176355","article-title":"Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia \u2013 a cross-sectional survey","volume":"13","author":"Alqarni","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.gloepi.2023.100113_bb0100","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2147\/PPA.S106821","article-title":"Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors","volume":"10","author":"Polonsky","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"12","key":"10.1016\/j.gloepi.2023.100113_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0207583","article-title":"Medication adherence among patients with type 2 diabetes: a mixed methods study","volume":"13","author":"Aloudah","year":"2018","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100113_bb0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.46542\/pe.2022.221.795804","article-title":"Impact of pharmacist-led education on knowledge, adherence, and glycaemic control of type 2 diabetic outpatients","volume":"22","author":"Suprapti","year":"2022","journal-title":"Pharm Educ"},{"issue":"3","key":"10.1016\/j.gloepi.2023.100113_bb0115","first-page":"94","article-title":"Diabetes support groups improve patient\u2019s compliance and control blood glucose levels","volume":"2","author":"Izzah","year":"2013","journal-title":"Indones J Clin Pharm"},{"key":"10.1016\/j.gloepi.2023.100113_bb0120","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2147\/PPA.S81612","article-title":"Determinants of medication adherence among adults with type 2 diabetes mellitus in three Malaysian public health clinics: a cross-sectional study","volume":"9","author":"Chew","year":"2015","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100113_bb0125","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s40200-020-00583-4","article-title":"Glycemic control and associated factors among Iranian population with type 2 diabetes mellitus: a cross-sectional study","volume":"19","author":"Babaniamansour","year":"2020","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.gloepi.2023.100113_bb0130","first-page":"40","article-title":"Factors impacting on diabetes knowledge, medication adherence and glycemic control among adult diabetics visiting a county teaching and referral hospital in Kenya: a cross-sectional study","author":"Mwangasha","year":"2021","journal-title":"Pan Afr Med J"},{"issue":"3","key":"10.1016\/j.gloepi.2023.100113_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023401","article-title":"Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela","volume":"9","author":"Duarte","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100113_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-022-00974-z","article-title":"Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study","volume":"22","author":"Abera","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"10.1016\/j.gloepi.2023.100113_bb0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1573399814666180510144858","article-title":"Factors associated with poor hemoglobin A1c control in patients with type 2 diabetes","volume":"15","author":"Alqudah","year":"2018","journal-title":"Curr Diabetes Rev"},{"issue":"5","key":"10.1016\/j.gloepi.2023.100113_bb0150","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1248\/bpb.b20-00898","article-title":"Predictors of glycemic control among patients with type 2 diabetes in western China: a multi-center cross sectional study","volume":"44","author":"Xiang","year":"2021","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.gloepi.2023.100113_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2042018820980225","article-title":"Should metformin remain the first-line therapy for treatment of type 2 diabetes?","volume":"12","author":"Baker","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.gloepi.2023.100113_bb0160","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s40265-021-01618-7","article-title":"Clinical value of emerging bioanalytical methods for drug measurements: a scoping review of their applicability for medication adherence and therapeutic drug monitoring","volume":"81","author":"Zijp","year":"2021","journal-title":"Drugs."},{"key":"10.1016\/j.gloepi.2023.100113_bb0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/DMSO.S185614","article-title":"Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia","volume":"12","author":"Fasil","year":"2019","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100113_bb0170","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.chest.2020.03.012","article-title":"Cross-sectional studies: strengths, weaknesses, and recommendations","volume":"158","author":"Wang","year":"2020","journal-title":"Chest."},{"issue":"4","key":"10.1016\/j.gloepi.2023.100113_bb0175","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/aje\/kwac037","article-title":"Can cross-sectional studies contribute to causal inference? It depends","volume":"192","author":"Savitz","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.gloepi.2023.100113_bb0180","first-page":"210","article-title":"Clinical prediction models a practical approach to development, validation, and updating","volume":"54\u201356","author":"Steyerberg","year":"2019","journal-title":"Second Cham: Springer Nat"},{"issue":"7549","key":"10.1016\/j.gloepi.2023.100113_bb0185","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.gloepi.2023.100113_bb0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea","volume":"25","author":"Royston","year":"2006","journal-title":"Stat Med"}],"container-title":["Global Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590113323000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590113323000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:47:52Z","timestamp":1762912072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590113323000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"alternative-id":["S2590113323000160"],"URL":"https:\/\/doi.org\/10.1016\/j.gloepi.2023.100113","relation":{},"ISSN":["2590-1133"],"issn-type":[{"value":"2590-1133","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of medication adherence and glycemic control among patients with type 2 diabetes and influencing factors: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Global Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gloepi.2023.100113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100113"}}